BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2891464)

  • 1. Recognition and treatment of attention deficit disorder.
    Bond WS
    Clin Pharm; 1987 Aug; 6(8):617-24. PubMed ID: 2891464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit hyperactivity disorder.
    Calis KA; Grothe DR; Elia J
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology, medical management, and dental implications of children and young adults having attention-deficit hyperactivity disorder.
    Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
    J Calif Dent Assoc; 2003 Sep; 31(9):669-78. PubMed ID: 14560871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulants and antidepressant pharmacokinetics in hyperactive children.
    Elia J
    Psychopharmacol Bull; 1991; 27(4):411-5. PubMed ID: 1687612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond methylphenidate: nonstimulant medications for youth with ADHD.
    Wood JG; Crager JL; Delap CM; Heiskell KD
    J Atten Disord; 2007 Nov; 11(3):341-50. PubMed ID: 17932386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder.
    Shaywitz BA; Fletcher JM; Shaywitz SE
    Adv Pediatr; 1997; 44():331-67. PubMed ID: 9265975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical recognition and management of adult attention deficit hyperactivity disorder.
    Craig C
    Nurse Pract; 1996 Nov; 21(11):101-6, 108. PubMed ID: 8933539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.